Ownership history in UBS Group AG · 7 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in AIMEI HEALTH TECHNOLOGY CO L (AFJK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,314 | -2,643 | -66.8% | 0.00% | $84K | $64.01 |
| 2025 Q3 | REDUCED | 3,957 | -344 | -8.0% | 0.00% | $45K | $11.32 |
| 2025 Q2 | ADDED | 4,301 | +1 | +0.0% | 0.00% | $48K | $11.15 |
| 2025 Q1 | UNCHANGED | 4,300 | — | 0% | 0.00% | $47K | $11.00 |
| 2024 Q4 | ADDED | 4,300 | +3,095 | +256.8% | 0.00% | $46K | $10.70 |
| 2024 Q2 | ADDED | 1,205 | +1,171 | +3444.1% | 0.00% | $12K | $10.35 |
| 2024 Q1 | INITIATED | 34 | — | — | 0.00% | $347 | — |
As of 2025 Q4 — sorted by position size